New paper (Violette): OTC HIV PrEP Support Among Transfeminine People
New paper led by Lauren Violette in JAMA Network Open: Support for Over-the-Counter HIV Preexposure Prophylaxis among Transfeminine People. The analysis drew on the 2023-2024 Transgender Women’s Internet Survey and Testing study, an online cross-sectional survey of 1936 transgender women and transfeminine nonbinary people from all 50 states, 1684 of whom (87.0%) had never used preexposure prophylaxis (PrEP). Support for over-the-counter (OTC) PrEP availability was reported by 1677 respondents (86.6%), compared with 127 (6.6%) who did not support it and 114 (5.9%) who were unsure. Support was higher among respondents reporting 10 or more sex partners in the prior 12 months than among those reporting 0 to 1 (prevalence ratio 1.09, 95% CI 1.05-1.12).